Effectiveness of Intravitreal Ranibizumab in Nonvitrectomized and Vitrectomized Eyes with Diabetic Macular Edema: A Two-Year Retrospective Analysis

Table 2

Baseline ocular measurements of the study groups.

	Total (n = 28 eyes)	Nonvitrectomized (n = 17 eyes)	Vitrectomized (n = 11 eyes)
BCVA (logMAR)	0.59 ± 0.29	0.51 ± 0.26	0.70 ± 0.3	0.084
CMT (μm)	337.57 ± 95.53	342.41 ± 98.31	330.09 ± 95.26	0.746
TMV (mm³)	9.16 ± 1.36	9.04 ± 1.28	9.35 ± 1.52	0.568

Data are presented as mean and standard deviation. BCVA was measured with a standard Snellen chart and converted to the logarithm of the minimum angle of resolution (logMAR) units. BCVA indicates best-corrected visual acuity; CMT, central macular thickness; TMV, total macular volume. Student’s t-test.